Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 2
2010 2
2011 3
2012 2
2014 1
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Omalizumab: not only for asthma.
Ben-Shoshan M. Ben-Shoshan M. Recent Pat Inflamm Allergy Drug Discov. 2008 Nov;2(3):191-201. doi: 10.2174/187221308786241910. Recent Pat Inflamm Allergy Drug Discov. 2008. PMID: 19076009 Review.
Although omalizumab is generally well tolerated, reports on potential anaphylactic reactions as well as an association with Churg-Strauss syndrome necessitate close monitoring. The data reviewed are discussed with the aim of underlining unmet needs and making recommendatio …
Although omalizumab is generally well tolerated, reports on potential anaphylactic reactions as well as an association with Churg-Strauss
Radiation countermeasure agents: an update.
Dumont F, Le Roux A, Bischoff P. Dumont F, et al. Expert Opin Ther Pat. 2010 Jan;20(1):73-101. doi: 10.1517/13543770903490429. Expert Opin Ther Pat. 2010. PMID: 20021286 Review.
Current update on eosinophilic lung diseases and anti-IL-5 treatment.
Samitas K, Rådinger M, Bossios A. Samitas K, et al. Recent Pat Antiinfect Drug Discov. 2011 Sep 1;6(3):189-205. doi: 10.2174/157489111796887855. Recent Pat Antiinfect Drug Discov. 2011. PMID: 21824072 Review.
Peripheral blood eosinophilia and eosinophilic lung inflammation are common in a variety of pulmonary conditions, including eosinophilic pneumonia and asthma, hypereosinophilic syndrome and Churg-Strauss syndrome. Therapy in most of these clinical entities consists of long …
Peripheral blood eosinophilia and eosinophilic lung inflammation are common in a variety of pulmonary conditions, including eosinophilic pne …
[Interferon-alpha treatment of the Churg-Strauss syndrome].
Reissig A, Förster M, Mock B, Schilder C, Kroegel C. Reissig A, et al. Dtsch Med Wochenschr. 2003 Jul 4;128(27):1475-8. doi: 10.1055/s-2003-40284. Dtsch Med Wochenschr. 2003. PMID: 12840770 German.
HISTORY: Two patients, 60 (pat. 1; female) and 30 years of age (pat. 2; male), respectively, suffering from a histologically confirmed Churg-Strauss-syndrome and receiving immunosuppressive therapy were treated with Interferon-alpha. ...In addition, the propo …
HISTORY: Two patients, 60 (pat. 1; female) and 30 years of age (pat. 2; male), respectively, suffering from a histologically c …
Percutaneous aspiration thrombectomy for the treatment of arterial thromboembolic occlusions following percutaneous transluminal angioplasty.
Schleder S, Diekmann M, Manke C, Heiss P. Schleder S, et al. Cardiovasc Intervent Radiol. 2015 Feb;38(1):60-4. doi: 10.1007/s00270-014-0857-6. Epub 2014 Mar 7. Cardiovasc Intervent Radiol. 2015. PMID: 24599522
PURPOSE: This study was designed to evaluate the technical success and the early clinical outcome of patients undergoing percutaneous aspiration thrombectomy (PAT) for the treatment of arterial thromboembolism following percutaneous infrainguinal transluminal angioplasty ( …
PURPOSE: This study was designed to evaluate the technical success and the early clinical outcome of patients undergoing percutaneous aspira …
11 results